# A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

> clinical trial · VERIFIED · 2026-07-14

Status: RECRUITING · Sponsor: BlossomHill Therapeutics · Condition: NSCLC (Advanced Non-small Cell Lung Cancer)

- Company: BlossomHill Therapeutics
- Sector: NSCLC (Advanced Non-small Cell Lung Cancer)
- Primary source: https://clinicaltrials.gov/study/NCT06706076

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.